A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants with Moderate Hepatic Impairment

Trial Identifier:	D3615C00004
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	January 2026
Primary Completion Date:	July 2026
Study Completion Date:	July 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Rialto, CA, US, 92377
US, TX	San Antonio, TX, US, 78215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.